Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| SEER Robotics | 2025 | Series C | $9.6M | Shanghai |
| Harbour Biomed | 2025 | Post Ipo Equity | $105.0M | Shanghai |
| ReviR Therapeutics | 2025 | Grant | $4.6M | Brisbane |
| Neomodulus | 2025 | Series C | $40.8M | Suzhou |
| Yida Technology | 2024 | Series B | Undisclosed | Shanghai |
| Spear Bio | 2024 | Series A | $45.0M | Weston |
| IASO Biotherapeutics | 2024 | Corporate Round | Undisclosed | Nanjing |
| Vision Medicals | 2024 | Series D | Undisclosed | Guangzhou |
| Ruijiakang | 2024 | Series A | $1.4M | Wuhan |
| CYGNUSEMI | 2024 | Series B | $69.1M | Shanghai |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | SEER Robotics | Series C | $9.6M | Shanghai, China |
| 52 | Harbour Biomed | Post Ipo Equity | $105.0M | Shanghai, China |
| 53 | ReviR Therapeutics | Grant | $4.6M | Brisbane, United States |
| 54 | Neomodulus | Series C | $40.8M | Suzhou, China |
| 55 | Yida Technology | Series B | Undisclosed | Shanghai, China |
| 56 | Spear Bio | Series A | $45.0M | Weston, United States |
| 57 | IASO Biotherapeutics | Corporate Round | Undisclosed | Nanjing, China |
| 58 | Vision Medicals | Series D | Undisclosed | Guangzhou, China |
| 59 | Ruijiakang | Series A | $1.4M | Wuhan, China |
| 60 | CYGNUSEMI | Series B | $69.1M | Shanghai, China |
Shanghai Seer Intelligent Technology is a firm that provides a product portfolio for integrators, mobile robots, and digital software.
Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Nuoyimeier is a developer of implantable consumables.
Yida Technology is a digital robot company that creates industrialized digital robots and other products.
Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.
Vision Medicals is a gene technology and precision medicine company.
Ruijiakang focuses on the development and implementation of green synthetic biology manufacturing.
Cygnusemi is a semiconductor chip technology company that focuses on 5G IoT applications.
Bach Hoa Xanh is a chain of minimarts and food stores that concentrate in fresh produce and everyday household necessities.
Snow Tech provides digital security products and services that supports local and SAAS deployment.
TechnoDerma Medicines is engaged in the research and development of skin drugs for external use.
Dakang Medical is a chain of independent blood purification medical service institutions.
Hithium Energy Storage is a tech enterprise, specializing in the R&D, production, and sales of lithium-ion battery core materials.
SVOLT is an energy tech company that specializes in the manufacturing of automotive power batteries and energy storage systems.
Qitan Technology is a Developer of a genome sequencing technology.
Corerain provides AI acceleration solutions to embedding frontend, edge, and backend AI devices.
Ceram Pharmaceuticals is a biotech firm that uses epigenetics to carry out R&D of drugs and diagnostic treatments for cancer and diseases.
Wiling Medical offers extensive knowledge of the principles and clinical uses of implantable brain-computer interfaces.
Chuangjian Medical Technology focuses on the creation, sale, and research & development of novel protein and nucleic acid-based medicines.
Formal-Tech is a embedded software company that offers development and production of high-safety industrial control software and hardware.
Jianwang Technology is a high-tech enterprise that specializes in smart energy solutions and is deeply involved in the new energy business.
Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.
ForwardX Robotics specializes in R&D of computer vision robots that apply to consumer and business products.
CDH Investments has invested in 137 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
CDH Investments's top investment sectors include Biotechnology, Health Care, Medical, Manufacturing, Pharmaceutical. The firm invests across 41 different industry categories.
Among tracked funding rounds, Harbour Biomed received $105.0M in a Post Ipo Equity round. CDH Investments's total known invested capital is $6.2B.
CDH Investments's average investment size is $73.5M across its portfolio of 137 companies.
Recent CDH Investments portfolio additions include SEER Robotics, Harbour Biomed, ReviR Therapeutics, Neomodulus, Yida Technology. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors